Dexcom (DXCM) Gross Margin (2010 - 2026)
Dexcom's (DXCM) quarterly Gross Margin came in at 63.44% in Q2 2026, up 391.0% year-over-year from 12.92% in Q2 2025, and up 0.77% quarter-over-quarter from 62.95% in Q1 2026.
Powered by 
Analysis
Dexcom (DXCM) Gross Margin (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Gross Margin for 17 consecutive years, with 63.44% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Gross Margin rose 391.0% year-over-year to 63.44% in Q2 2026; TTM through Jun 2026 was 62.47%, a 371.0% increase from a year earlier, with the FY2025 full-year figure at 60.1%, down 36.0% from the prior year.
- Gross Margin was 63.44% for Q2 2026 at Dexcom, up from 62.95% in the prior quarter.
- Over five years, Gross Margin peaked at 66.4% in Q4 2022 and troughed at 56.85% in Q1 2025.
- A 5-year average of 62.18% and a median of 62.82% in 2025 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin slumped 552 bps in 2022 and soared 610 bps in 2026, its largest moves.
- Over 5 years, Gross Margin stood at 66.4% in 2022, then dropped by 4 bps to 63.47% in 2023, then fell by 7 bps to 58.9% in 2024, then increased by 7 bps to 62.93% in 2025, then climbed by 1 bps to 63.44% in 2026.
- The last three Gross Margin figures came in at 63.44% (Q2 2026), 62.95% (Q1 2026), and 62.93% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 57.71% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 67.78% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 64.99% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 68.27% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 70.71% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 77.46% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 60.21% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 63.44% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 45.84% |
| 10 | Zimmer Biomet Holdings | 18.70 Bn | 18.30 Bn | 1.54 Bn | 70.81% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 63.44% |
| Mar 31, 2026 | 62.95% |
| Dec 31, 2025 | 62.93% |
| Sep 30, 2025 | 60.48% |
| Jun 30, 2025 | 59.53% |
| Mar 31, 2025 | 56.85% |
| Dec 31, 2024 | 58.90% |
| Sep 30, 2024 | 59.73% |
| Jun 30, 2024 | 62.40% |
| Mar 31, 2024 | 61.01% |
| Dec 31, 2023 | 63.47% |
| Sep 30, 2023 | 63.93% |
| Jun 30, 2023 | 62.71% |
| Mar 31, 2023 | 62.39% |
| Dec 31, 2022 | 66.40% |
| Sep 30, 2022 | 64.22% |
| Jun 30, 2022 | 64.56% |
| Mar 31, 2022 | 63.31% |
| Dec 31, 2021 | 67.69% |
| Sep 30, 2021 | 68.73% |